Henrique Rodrigues

Researcher

University of Arkansas for Medical Sciences

faculty

5 h-index 24 pubs 254 cited

Research Areas

Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Pancreatic and Hepatic Oncology Research Diet and metabolism studies Epigenetics and DNA Methylation Radiation Therapy and Dosimetry MicroRNA in disease regulation Cancer Genomics and Diagnostics

Links

Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Henrique Rodrigues' research investigates mechanisms to enhance cancer radiosensitivity, with a particular focus on pancreatic, thyroid, and rectal cancers. His work has explored targeting specific molecular pathways, such as the RAS-RAF-miR-296-3p signaling axis to modulate Rad18 expression in pancreatic and thyroid cancers. Additionally, his research has examined the role of SETD2 inhibition in combination with radiotherapy for rectal cancer and the impact of methionine restriction in enhancing radiosensitivity for KRAS mutant rectal cancer.

Rodrigues also studies the inhibition of Cyclin-Dependent Kinase 1 (CDK1) as a strategy to improve the radiosensitivity of pancreatic cancer. His publications include research on enhancing gut protection alongside radiosensitivity through dietary modifications like methionine restriction. He has co-authored 24 publications, accumulating 254 citations and an h-index of 5. His collaborations include work with Oscar Zuniga, Lokesh Akana, Nükhet Aykin‐Burns, and Isabelle Racine Miousse at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 5
  • Publications: 24
  • Citations: 254

Selected Publications

  • Abstract A033: Targeting SETD2 in Combination with Radiotherapy in Rectal Cancer (2025) DOI
  • Enhancing Rectal Cancer Radiosensitivity and Gut Protection through Methionine Restriction (2025) DOI
  • Abstract A011: Enhanced Radiosensitivity of Pancreatic Cancer Achieved through Inhibition of Cyclin-Dependent Kinase 1 (2024) DOI
  • RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers (2024) DOI
  • Abstract A006: Targeting SETD2 in combination with radiotherapy in rectal cancer (2024) DOI
  • Abstract 2839: Methionine restriction radiosensitizes KRAS mutant rectal cancer (2023) DOI

Collaborators

Researchers in the database who share publications

Oscar Zuniga University of Arkansas for Medical Sciences 4 shared publications Lokesh Akana University of Arkansas for Medical Sciences 4 shared publications Nükhet Aykin‐Burns University of Arkansas for Medical Sciences 2 shared publications Isabelle Racine Miousse University of Arkansas for Medical Sciences 2 shared publications Sarita Garg University of Arkansas for Medical Sciences 2 shared publications Stetson Van Matre University of Central Arkansas 2 shared publications Robin Eluvathingal University of Arkansas for Medical Sciences 1 shared publication Tatiana Wolfe University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

Lokesh Akana University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Pancreatic and Hepatic Oncology Research
Strong match 6 shared topics
Oscar Zuniga University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Pancreatic and Hepatic Oncology Research
Good match 5 shared topics
Jim Zhongning Chen University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Diet and metabolism studies
Good match 5 shared topics
M. J. Birrer University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research MicroRNA in disease regulation
Good match 4 shared topics
Narayanasamy Ganesh University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Radiation Therapy and Dosimetry
Good match 3 shared topics
Robin Eluvathingal University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Cancer-related molecular mechanisms research Diet and metabolism studies
Good match 3 shared topics